Vijaya Diagnostics Centre limited is a leading diagnostic medicare services provider in Southern India and offers comprehensive services that include nuclear medicine,
Vijaya Diagnostic Centre Ltd Q3FY25; 35% rise in Profits
Categories
laboratories
Neuland Laboratories Ltd Q4FY24; 20% fall in Profits
Neuland Laboratories is engaged in manufacturing and selling of bulk drugs and caters to both domestic and international markets. Financial Results: Neuland
Metropolis Healthcare Ltd Q4FY24; 12% rise in Profits
Metropolis Healthcare Limited is one of the leading Indian diagnostics companies. The Company owns a chain of diagnostic centres across India, South
Neuland Laboratories Limited Q4 FY24 Earnings Conference Call Insights
Key highlights from Neuland Laboratories Limited (NEULANDLAB) Q4 FY24 Earnings Concall Financial Performance Total income for FY '24 was INR 1,511 crores,
Thyrocare Technologies Ltd Q4FY24; 90% rise in Profits
Thyrocare Technologies is engaged in the business of healthcare industry and is involved in providing quality diagnostic services at affordable costs to
Vijaya Diagnostic Centre Ltd Q4FY24; 21% rise in Profits
Vijaya Diagnostics Centre limited is a leading diagnostic medicare services provider in Southern India and offers comprehensive services that include nuclear medicine,
Thyrocare Technologies Ltd Q3FY24; 15% rise in Profits
Thyrocare Technologies is engaged in the business of healthcare industry and is involved in providing quality diagnostic services at affordable costs to
Divi’s Laboratories Ltd Q3FY24; 17% rise in Profits
Incorporated in 1990, Divis Laboratories Ltd manufactures and exports API's, Intermediates and Nutraceutical ingredients Financial Results: Divi's Laboratories Ltd reported Revenues for
Dr Lal Pathlabs Ltd Q3FY24; 52% rise in Profits
Dr. Lal PathLabs Limited is one of India’s leading consumer healthcare brand in diagnostic services. It has an integrated nationwide network, where
Dr Reddy’s Laboratories Ltd Q3FY24; 11% rise in Profits
Dr. Reddy's Laboratories Ltd is a leading India-based pharamceutical company which offers a portfolio of products and services, including Active Pharmaceutical Ingredients
Vijaya Diagnostic Centre Ltd Q3FY24; 62% rise in Profits
Vijaya Diagnostics Centre limited is a leading diagnostic medicare services provider in Southern India and offers comprehensive services that include nuclear medicine,
Vijaya Diagnostic Centre Ltd Q2FY24; 48% rise in Profits
Vijaya Diagnostics Centre limited is a leading diagnostic medicare services provider in Southern India and offers comprehensive services that include nuclear medicine,
Thyrocare Technologies Ltd Q2FY24; 43% rise in Profits
Thyrocare Technologies is engaged in the business of healthcare industry and is involved in providing quality diagnostic services at affordable costs to
Vijaya Diagnostic Centre Ltd Q1FY24; 44% rise in Profits
Vijaya Diagnostics Centre limited is a leading diagnostic medicare services provider in Southern India and offers comprehensive services that include nuclear medicine,
Thyrocare Technologies Ltd Q1FY24; 5% fall in Profits
Thyrocare Technologies is engaged in the business of healthcare industry and is involved in providing quality diagnostic services at affordable costs to
IPCA Laboratories Q4FY23; 42% Fall in Profits
IPCA Laboratories Ltd.’s revenue in Q4FY23 rose 17% to ₹ 1,511 crores. Consolidated Profit After Tax came at ₹ 81 crores in
Vijaya Diagnostics Centre Ltd Q4FY23 results out, revenue grows by 4%
Vijaya Diagnostics Centre limited is a leading diagnostic medicare services provider in Southern India and offers comprehensive services that include nuclear medicine,
Neuland Laboratories Limited Q3 FY23 Earnings Conference Call Insights
Key highlights from Neuland Laboratories Limited (NEULANDLAB) Q3 FY23 Earnings Concall Management Update: [00:05:35] NEULANDLAB said its raw material prices are becoming
Dr. Reddy’s Laboratories (DRREDDY) Q3 FY22 Earnings Concall Transcript
Dr. Reddy's Laboratories (NSE:DRREDDY) Q3 FY22 Earnings Concall dated Jan. 28, 2022 Corporate Participants: Amit Agarwal -- Head of Investor Relations Parag